These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3022264)
1. [Neuropeptides and the pathogenesis and treatment of endogenous mental disorders]. Puzyński S Postepy Biochem; 1985; 31(3-4):509-30. PubMed ID: 3022264 [No Abstract] [Full Text] [Related]
2. [Psychotropic effect of clonidine--the role of alpha 2 adrenergic receptors in the pathogenesis of mental disorders]. Kasperowicz-Dabrowiecka A; Rybakowski J Psychiatr Pol; 1990; 24(2):151-9. PubMed ID: 1982183 [No Abstract] [Full Text] [Related]
4. [Clinical and biochemical aspects of the prevention of depression]. Rybakowski J Psychiatr Pol; 1987; 21(3):212-9. PubMed ID: 2827213 [No Abstract] [Full Text] [Related]
5. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy]. Wunderlich H; Wunderlich HP Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615 [No Abstract] [Full Text] [Related]
6. Neuropeptide influences on the development of their receptors. Handelmann GE Prog Brain Res; 1988; 73():523-33. PubMed ID: 2458616 [No Abstract] [Full Text] [Related]
8. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
9. Ernst Klenk Lecture, November 1987. Molecular studies in neuroscience: implications for medicine. Bloom FE Biol Chem Hoppe Seyler; 1991 Apr; 372(4):245-54. PubMed ID: 1676270 [No Abstract] [Full Text] [Related]
10. [New options in the treatment of depression]. Frieling H; Hillemacher T; Demling JH; Kornhuber J; Bleich S Fortschr Neurol Psychiatr; 2007 Nov; 75(11):641-52. PubMed ID: 17366379 [TBL] [Abstract][Full Text] [Related]
11. Integrating the neurobiology of schizophrenia. Preface. Abi-Dargham A; Guillin O Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855 [No Abstract] [Full Text] [Related]
12. [Dimensional approach to trans-nosographic study of psychotropic drugs]. Jouvent R Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355 [No Abstract] [Full Text] [Related]
13. Neuropeptides: relevance in treatment of depression and anxiety disorders. Madaan V; Wilson DR Drug News Perspect; 2009; 22(6):319-24. PubMed ID: 19771321 [TBL] [Abstract][Full Text] [Related]
14. Involvement of neuropeptide systems in schizophrenia: human studies. Cáceda R; Kinkead B; Nemeroff CB Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866 [TBL] [Abstract][Full Text] [Related]
15. [Paraclinical factors for predicting response to antidepressive agents in depressive states]. Vanelle JM Encephale; 1995 Dec; 21 Spec No 4():23-6. PubMed ID: 8808342 [No Abstract] [Full Text] [Related]
16. Neuropeptides in psychiatric diseases: an overview with a particular focus on depression and anxiety disorders. Belzung C; Yalcin I; Griebel G; Surget A; Leman S CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):135-45. PubMed ID: 16611088 [TBL] [Abstract][Full Text] [Related]